UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in three segments, Hong Kong & Macau Corporate Healthcare Solution Services, Hong Kong & Macau Clinical Healthcare Services, and Mainland China Clinical Healthcare Services. The company offers general practice and family medicine; specialist consultation services, including internal medicine, surgery, pediatrics, cardiology, dermatology, otorhinolaryngology, orthopedics, ophthalmology, urology, gastroenterology and hepatology, radiology, endocrinology, and diabetes; and dental care services, such as dental implant, cosmetic dentistry, periodontal treatments, and orthodontics, as well as traditional Chinese medicines. It also provides physiotherapy services comprising muscle-strengthening, limb function, eye-hand coordination, and hand function trainings; day surgery and endoscopy; diagnostic imaging and laboratory; preventive medicines and health assessment; visa medical examination; vaccination and consultation; vision care and optometry; plastic, head, and neck surgeries; medical and cosmetics dermatology, and aesthetics; chronic disease management, such as hypertension, cardiovascular disease, diabetes, and joint diseases; and corporate healthcare solutions and third party administration services. In addition, the company offers WeWell Healthcare, a health service platform for family health management, recommending, and arranging professional medical and health services for each family member, including health checkup, vaccinations, and other specialist medical services referrals, etc. Further, it provides specialist consultation services. It serves insurance companies and corporations, and self-paid patients. The company was founded in 1990 and is headquartered in Central, Hong Kong.
Show more
-
TA Corporation Ltd. Completes Debt Restructuring and Updates on SGX Resumption Conditions – January 2026
January 30, 2026
TA Corporation Ltd.: Key Updates on Debt Restructuring and Resumption Proposal TA Corporation Ltd. Provides Key Update on Debt Restructuring and Resumption Conditions Overview TA…
-
Kuala Lumpur High Court Sets Aside Arbitration Award in GLM Emerald Hills vs Barisan Performa Case – GuocoLand Malaysia Update 1
January 29, 2026
Overview GuocoLand (Malaysia) Berhad (“GuocoLand”) has announced a significant development in its ongoing litigation involving its subsidiary, GLM Emerald Hills (Cheras) Sdn Bhd (“GLM EHills”),…
-
ASTI Holdings Limited Announces Resumption of Trading on SGX from 22 January 2026 After Prolonged Suspension 1
January 20, 2026
ASTI Holdings Limited Announces Resumption of Trading on SGX After Prolonged Suspension Singapore, 20 January 2026 – ASTI Holdings Limited (“ASTI” or “the Company”) has…
-
Singapore Market Update January 2026: CICT Hougang Deal, Trump Tariffs, and Key Stock Insights
January 19, 2026
Broker Name: Lim & Tan Securities Date of Report: 19 January 2026 Excerpt from Lim & Tan Securities report. Report Summary US stocks showed little…
-
Dow jumped 1.23% to a record close
January 5, 2026
U.S. stocks rose Monday despite the U.S. attack on Venezuela and the capture of President Nicolás Maduro, as investors bet the event would not spark…
-
ASTI Holdings Limited Announces Expected Resumption of Trading by January 2026
December 25, 2025
Key Highlights for Investors Resumption of Trading: ASTI Holdings Limited has announced that it is actively working towards the resumption of trading in its shares,…
-
Nvidia Reclaims Access to China’s $50B AI Market with H200 Chip Sales Approved by Trump 1
December 10, 2025
Excerpt from DBS report. Report Summary President Trump has approved the sale of Nvidia’s H200 AI chips to China, reversing previous restrictions, but a 25%…
-
Global Markets Weekly: US Fed Rate Cut Expectations, Trump’s Policy Moves, and Key Asia & Europe Stock Trends – 9 December 2025 Market Summary
December 9, 2025
Broker Name: OCBC Investment Research Date of Report: 9 December 2025 Excerpt from OCBC Investment Research report. Report Summary Global equities were mixed, with US…
-
Thai Beverage PLC Faces Demand Slump in FY25: Revenue Misses, Spirits Volume Drops, FY26 Outlook Adjusted 1
December 1, 2025
Broker Name: Not specified in the provided document Date of Report: Not specified in the provided document Excerpt from {broker} report. Report Summary: Thai Beverage…
-
TA Corporation Receives SGX RegCo No-Objection Letter for Trading Resumption Proposal and Debt Restructuring Approval 1
November 26, 2025
TA Corporation Ltd. Receives SGX RegCo No-Objection for Trading Resumption Proposal TA Corporation Ltd. Receives SGX RegCo No-Objection for Trading Resumption Proposal Key Highlights TA…
